|Global distribution and prevalence of hepatitis C virus genotypes|
JP Messina, I Humphreys, A Flaxman, A Brown, GS Cooke, OG Pybus, ...
Hepatology 61 (1), 77-87, 2015
|Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial|
PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ...
The Lancet 396 (10249), 467-478, 2020
|Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK|
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10269), 99-111, 2021
|Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man|
E Barnes, A Folgori, S Capone, L Swadling, S Aston, A Kurioka, J Meyer, ...
Science translational medicine 4 (115), 115ra1-115ra1, 2012
|High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection|
GM Lauer, E Barnes, M Lucas, J Timm, K Ouchi, AY Kim, CL Day, ...
Gastroenterology 127 (3), 924-936, 2004
|Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease|
R Banerjee, M Pavlides, EM Tunnicliffe, SK Piechnik, N Sarania, R Philips, ...
Journal of hepatology 60 (1), 69-77, 2014
|Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties|
E Billerbeck, YH Kang, L Walker, H Lockstone, S Grafmueller, V Fleming, ...
Proceedings of the National Academy of Sciences 107 (7), 3006-3011, 2010
|Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease|
NR West, AN Hegazy, BMJ Owens, SJ Bullers, B Linggi, S Buonocore, ...
Nature medicine 23 (5), 579-589, 2017
|A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory|
L Swadling, S Capone, RD Antrobus, A Brown, R Richardson, EW Newell, ...
Science translational medicine 6 (261), 261ra153-261ra153, 2014
|MAIT cells are activated during human viral infections|
B Van Wilgenburg, I Scherwitzl, EC Hutchinson, T Leng, A Kurioka, ...
Nature communications 7 (1), 1-11, 2016
|Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with …|
GR Foster, S Pianko, A Brown, D Forton, RG Nahass, J George, E Barnes, ...
Gastroenterology 149 (6), 1462-1470, 2015
|Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19|
Y Peng, AJ Mentzer, G Liu, X Yao, Z Yin, D Dong, W Dejnirattisai, ...
Nature immunology 21 (11), 1336-1345, 2020
|Genetic history of hepatitis C virus in East Asia|
OG Pybus, E Barnes, R Taggart, P Lemey, PV Markov, B Rasachak, ...
Journal of virology 83 (2), 1071-1082, 2009
|Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial|
MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ...
The Lancet 396 (10267), 1979-1993, 2020
|Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species|
S Colloca, E Barnes, A Folgori, V Ammendola, S Capone, A Cirillo, ...
Science translational medicine 4 (115), 115ra2-115ra2, 2012
|Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells|
LJ Walker, YH Kang, MO Smith, H Tharmalingham, N Ramamurthy, ...
Blood, The Journal of the American Society of Hematology 119 (2), 422-433, 2012
|Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort|
MT Huggett, EL Culver, M Kumar, JM Hurst, M Rodriguez-Justo, ...
The American journal of gastroenterology 109 (10), 1675, 2014
|Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission|
GS Cooke, I Andrieux-Meyer, TL Applegate, R Atun, JR Burry, ...
The lancet Gastroenterology & hepatology 4 (2), 135-184, 2019
|The dynamics of T‐lymphocyte responses during combination therapy for chronic hepatitis C virus infection|
E Barnes, G Harcourt, D Brown, M Lucas, R Phillips, G Dusheiko, ...
Hepatology 36 (3), 743-754, 2002
|Vaccination for hepatitis C virus: closing in on an evasive target|
J Halliday, P Klenerman, E Barnes
Expert review of vaccines 10 (5), 659-672, 2011